Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Meningitis outbreak shines light on compounding pharmacies.

Shaughnessy AF.

BMJ. 2012 Nov 5;345:e7432. doi: 10.1136/bmj.e7432. No abstract available.

PMID:
23129491
2.
3.

Causes and root causes of a multistate fungal meningitis outbreak.

Lipowski EE, Smith WT, Navarro RP.

J Am Pharm Assoc (2003). 2015 Mar-Apr;55(2):118. doi: 10.1331/JAPhA.2015.14220. No abstract available.

PMID:
25616150
4.

How gaps in regulation of compounding pharmacy set the stage for a multistate fungal meningitis outbreak.

Teshome BF, Reveles KR, Lee GC, Ryan L, Frei CR.

J Am Pharm Assoc (2003). 2014 Jul-Aug;54(4):441-5. doi: 10.1331/JAPhA.2014.14011.

PMID:
25063265
5.

Compounding pharmacies: before and after an inspection.

Kulkarni D, Ricketts S.

Int J Pharm Compd. 2013 Sep-Oct;17(5):358-62.

PMID:
24459779
6.

2013 State Compounding Legislation Tracker.

Miller DG.

Int J Pharm Compd. 2013 Sep-Oct;17(5):375-8. No abstract available.

PMID:
24459782
7.

Description of outbreaks of health-care-associated infections related to compounding pharmacies, 2000-12.

Staes C, Jacobs J, Mayer J, Allen J.

Am J Health Syst Pharm. 2013 Aug 1;70(15):1301-12. doi: 10.2146/ajhp130049. Review.

8.

Compounding pharmacies: a viable option, or merely a liability?

O'Brien D Jr, Cohen I, Kennedy DJ.

PM R. 2013 Nov;5(11):974-81. doi: 10.1016/j.pmrj.2013.10.001. No abstract available.

PMID:
24247017
9.

The "Lists": What Do They Mean?

Voliva J.

Int J Pharm Compd. 2016 Nov-Dec;20(6):477-479. No abstract available.

PMID:
28339386
10.

GMPs vs GCPs: manufacturing and compounding definitions.

Allen LV Jr.

Int J Pharm Compd. 2013 Sep-Oct;17(5):356. No abstract available.

PMID:
24459778
11.

Introduction to Quality Control in a Compounding Pharmacy.

Allen LV Jr.

Int J Pharm Compd. 2016 Nov-Dec;20(6):481-484. Review.

PMID:
28339387
12.

The U.S. Food and Drug Administration responds to the International Academy of Compounding Pharmacists' outsourcing letter.

[No authors listed]

Int J Pharm Compd. 2014 May-Jun;18(3):208. No abstract available.

PMID:
25306767
13.

U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List).

[No authors listed]

Int J Pharm Compd. 2016 Nov-Dec;20(6):457-458. No abstract available.

PMID:
28339383
14.

Compounding our problems--again.

Trissel LA.

Am J Health Syst Pharm. 2003 Mar 1;60(5):432. No abstract available.

PMID:
12635448
15.

Analytic Methods Used in Quality Control in a Compounding Pharmacy.

Allen LV Jr.

Int J Pharm Compd. 2017 Jan-Feb;21(1):31-37. Review.

PMID:
28346196
16.

Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.

Kastango ES.

JPEN J Parenter Enteral Nutr. 2012 Mar;36(2 Suppl):38S-39S. doi: 10.1177/0148607111434779. Epub 2012 Jan 24.

PMID:
22275322
17.

Bipartisan effort. Dems, GOP call for investigation into outbreak.

Zigmon J.

Mod Healthc. 2012 Oct 15;42(42):7, 16. No abstract available.

PMID:
23163083
18.

[Quality control in the pharmacy].

Cohen EH.

Pharm Weekbl. 1968 Apr 26;103(17):472-85. Dutch. No abstract available.

PMID:
5665059
19.

Compounding pharmacies: who is in charge?

Pergolizzi JV Jr, Labhsetwar S, LeQuang JA.

Pain Pract. 2013 Mar;13(3):253-7. doi: 10.1111/papr.12033. Epub 2013 Jan 28. Review. Erratum in: Pain Pract. 2013 Apr;13(4):347.

PMID:
23350709
20.

What gastroenterologists should know about the gray market, herbal remedies, and compounded pharmaceuticals and their regulation by the Food and Drug Administration.

Ehrenpreis ED, Kulkarni P, Burke C; FDA-Related Matters Committee of the American College of Gastroenterology.

Am J Gastroenterol. 2013 May;108(5):642-6. doi: 10.1038/ajg.2012.348. No abstract available.

PMID:
23644956

Supplemental Content

Support Center